Related references
Note: Only part of the references are listed.Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
Xin-Lin Zhang et al.
ANNALS OF INTERNAL MEDICINE (2016)
Safety and Efficacy of Everolimus-Versus Sirolimus-Eluting Stents 5-Year Results From SORT OUT IV
Lisette Okkels Jensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Michael Haude et al.
LANCET (2016)
Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys
Patrick K. Bowen et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Biodegradable polymer stents vs second generation drug eluting stents: A meta-analysis and systematic review of randomized controlled trials
Bhavi Pandya et al.
WORLD JOURNAL OF CARDIOLOGY (2016)
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial
Bent Raungaard et al.
LANCET (2015)
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W. Serruys et al.
LANCET (2015)
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
Stephen G. Ellis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Philip Urban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Georgios J. Vlachojannis et al.
EUROINTERVENTION (2015)
New stent surface materials: The impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets
Raila Busch et al.
ACTA BIOMATERIALIA (2014)
Long-Term Clinical Outcomes After Everolimus-and Sirolimus-Eluting Coronary Stent Implantation Final 3-Year Follow-Up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial
Hiroki Shiomi et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2014)
A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial
Shigeru Saito et al.
EUROPEAN HEART JOURNAL (2014)
A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation 6-and 12-Month Clinical and Multimodality Imaging Results
Stefan Verheye et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
Thomas Pilgrim et al.
LANCET (2014)
PARAMETERS OF ENDOTHELIAL FUNCTION ARE DEPENDENT ON POLYMERIC SURFACE MATERIAL
R. Busch et al.
BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK (2013)
Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: Final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial
Lamin King et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2013)
The Final 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent
Ajay J. Kirtane et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomized, Noninferiority Trial
Patrick W. Serruys et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent A Randomized, Controlled, Noninferiority Trial
Masahiro Natsuaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Michael Haude et al.
LANCET (2013)
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial
Pieter Cornelis Smits et al.
LANCET (2013)
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
Evald Hoj Christiansen et al.
LANCET (2013)
Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently
Shang-Hung Chang et al.
PLOS ONE (2013)
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
Sripal Bangalore et al.
CIRCULATION (2012)
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
Giulio G. Stefanini et al.
EUROPEAN HEART JOURNAL (2012)
Primary Endpoint Results of the EVOLVE Trial A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
Ian T. Meredith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Multicenter Randomized Trial Comparing Amphilimus-With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions
Didier Carrie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients The TWENTE Trial
Clemens von Birgelen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabate et al.
LANCET (2012)
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial
Edoardo Camenzind et al.
LANCET (2012)
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design
Lorenz Raeber et al.
EUROINTERVENTION (2012)
Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial
Dariusz Dudek et al.
EUROINTERVENTION (2012)
Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease The Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Trial
Steffen Massberg et al.
CIRCULATION (2011)
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
David E. Kandzari et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Polymer-Free Biolimus A9-Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model
Norio Tada et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization The ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent for Coronary Lesions) Randomized Trial
Duk-Woo Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Elvin Kedhi et al.
LANCET (2010)
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries
Christoph Kaiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Patrick W. Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
Patrick W. Serruys et al.
EUROINTERVENTION (2010)
Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial
Robert A. Byrne et al.
EUROPEAN HEART JOURNAL (2009)
A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents
Philip Moore et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys et al.
LANCET (2009)
Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period
Tina L. Pinto Slottow et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Endothelial cell recovery between comparator polymer-based drug-eluting stents
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease
Mitchell W. Krucoff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque Morphology
Shuzou Tanimoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease
Albert Schoemig et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Outcomes associated with drug-eluting and bare-metal stents:: a collaborative network meta-analysis
Christoph Stettler et al.
LANCET (2007)
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents:: a prospective, non-randomised multicentre trial
Raimund Erbel et al.
LANCET (2007)
Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions - The pivotal TAXUS ATLAS trial
Mark A. Turco et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden
Bo Lagerqvist et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated Stent implantation in patients with coronary artery disease
George Cesar Ximenes Meireles et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2007)
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis
Alain Joel Nordmann et al.
EUROPEAN HEART JOURNAL (2006)
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine encapsulated stent for treatment of native coronary artery lesions:: Clinical and angiographic results of the ENDEAVOR II trial
Jean Fajadet et al.
CIRCULATION (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Bare metal stent restenosis is not a benign clinical entity
Michael S. Chen et al.
AMERICAN HEART JOURNAL (2006)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
S Windecker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease -: Meta-analysis of randomized trials
A Kastrati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Randomized comparison of a titanium-nitride-oxide coated stent with a stainless steel Stent for coronary revascularization
S Windecker et al.
CIRCULATION (2005)
Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trial
YH Kim et al.
AMERICAN HEART JOURNAL (2005)
Evaluation of the medtronic (Driver) cobalt-chromium alloy coronary stent system
MH Sketch et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions - Angiographic follow-up of the DELIVER clinical trial
AJ Lansky et al.
CIRCULATION (2004)
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?
R Virmani et al.
CIRCULATION (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
GW Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Usefulness of a cobalt chromium coronary stent alloy
DJ Kereiakes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Intracoronary stenting and angiographic results:: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial
J Pache et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: The Tenax versus Nir Stent Study's longterm outcome
M Unverdorben et al.
AMERICAN HEART JOURNAL (2003)
In-stent restenosis in small coronary arteries - Impact of strut thickness
C Briguori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
